PARATHYROID HORMONE (NatparĀ®)

Clinical Indication

Post-trial continuation of treatment of chronic hypoparathyroidism when standard therapy alone is inadequate.

Date of classification

November 2017

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.